Calcium channel antibodies in patients with absence epilepsy

Calcium channel antibodies in patients with absence epilepsy

Autoimmunity has aroused interest in the last years as a contributory mechanism of epilepsy, especially in epilepsies with unknown cause or therapy resistance. Since the relationship of absence epilepsy (AE) with calcium channels is well established, we aimed to investigate related antibodies in pat...

Full description

Saved in:
Bibliographic Details
Published in:International journal of neuroscience Vol. 124; no. 7; pp. 486 - 490
Main Authors: Tektürk, P nar, Baykan, Betül, Ekizo lu, Esme, Ulusoy, Canan, Aydin-Özemir, Zeynep, çöz, Sema, K nay, Demet, Tüzün, Erdem
Format: Journal Article
Language:English
Published: England Informa Healthcare 01-07-2014
Taylor & Francis
Subjects:
absence epilepsy
Adolescent
Adult
Autoantibodies - blood
autoimmunity
Calcium Channels - immunology
channelopathy
Child
Epilepsy, Absence - blood
Epilepsy, Absence - immunology
Female
Humans
Male
Middle Aged
Young Adult
autoimmunity
absence epilepsy
channelopathy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Autoimmunity has aroused interest in the last years as a contributory mechanism of epilepsy, especially in epilepsies with unknown cause or therapy resistance. Since the relationship of absence epilepsy (AE) with calcium channels is well established, we aimed to investigate related antibodies in patients diagnosed with AE. Consecutive patients with typical absence seizures having either childhood absence epilepsy (CAE) or juvenile absence epilepsy (JAE) with generalized spike and wave discharges on electroencephalography (EEG) were included after their consent. The patients were diagnosed according to the International League Against Epilepsy (ILAE) 2010 criteria. Antibodies against P-Q type voltage gated calcium channels (VGCC) and T-type VGCC subunit Cav3.2 (encoded by the CACNA1H gene) were investigated by RIA and ELISA, respectively. We searched for these antibodies in 32 patients with AE and 53 patients with focal epilepsy of unknown cause (FEOUC) as the disease control group; furthermore, 30 healthy persons served as the healthy controls. Eleven patients (34.3%) with AE had CAE and the remaining patients had JAE. Only a 47-year-old female FEOUC patient, who also had systemic lupus erythematosus with normal MRI scans showed antibodies against P-Q type VGCC, whereas no antibody positivity could be found in other FEOUC and AE patients and healthy controls. Our results might suggest that calcium channel antibodies do not play an important role in the pathophysiology of AE. Further studies with larger groups of other epileptic syndromes are needed to confirm our results.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0020-7454
1563-5279
1543-5245
DOI:10.3109/00207454.2013.858337